A prospective observational cohort study of the efficacy of tofacitinib plus iguratimod on rheumatoid arthritis with usual interstitial pneumonia

A prospective observational cohort study of the efficacy of tofacitinib plus iguratimod on rheumatoid arthritis with usual interstitial pneumonia

ObjectivesThis study aims to assess the efficacy of tofacitinib (TOF) plus iguratimod (IGU) in rheumatoid arthritis (RA) with usual interstitial pneumonia (UIP) (RA-UIP).MethodsThis was a prospective observational cohort, single-center study. Data from 78 RA-UIP patients treated with TOF plus IGU, I...

Full description

Bibliographic Details
Main Authors: Shuhua Wang, Yao Li, Yanchun Tang, Weilin Xie, Yue Zhang, Qingyan Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Immunology
Subjects:
rheumatoid arthritis with usual interstitial pneumonia
tofacitinib plus iguratimod
conventional synthetic disease-modifying anti-rheumatic drugs
dual treat-to-target
efficacy
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1215450/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1215450/full

Similar Items